Aurobindo and Intas submit binding offers to buyout Teva UK
Advertisement
Advertisement
Aurobindo and Intas, the drug makers from India, are among the final contenders in the list of buyers for the UK and Irish business of Israeli generics maker Teva. Both Indian companies have submitted binding offers of about $1 billion along with firm financing commitments, multiple sources aware of the matter told ET.
Teva is selling its assets after it acquired Allergan Plc's generics business for $40.5-billion in July last year. Prior to that, around 80 of its products in the US were sold to drug makers like Dr. Reddy's, Sagent, Cipla, Zydus Cadila, Aurobindo and Perrigo.
Aurobindo and Intas are in competition with London-based PE firm
It could still take some weeks for the buyer to get finalised, and preference would be given to someone with prior experience in the European generics market.
Advertisement
For
Image source
Advertisement
- I spent $2,000 for 7 nights in a 179-square-foot room on one of the world's largest cruise ships. Take a look inside my cabin.
- Colon cancer rates are rising in young people. If you have two symptoms you should get a colonoscopy, a GI oncologist says.
- Saudi Arabia wants China to help fund its struggling $500 billion Neom megaproject. Investors may not be too excited.
- Catan adds climate change to the latest edition of the world-famous board game
- Tired of blatant misinformation in the media? This video game can help you and your family fight fake news!
- Tired of blatant misinformation in the media? This video game can help you and your family fight fake news!
- JNK India IPO allotment – How to check allotment, GMP, listing date and more
- Indian Army unveils selfie point at Hombotingla Pass ahead of 25th anniversary of Kargil Vijay Diwas
- JNK India IPO allotment date
- JioCinema New Plans
- Realme Narzo 70 Launched
- Apple Let Loose event
- Elon Musk Apology
- RIL cash flows
- Charlie Munger
- Feedbank IPO allotment
- Tata IPO allotment
- Most generous retirement plans
- Broadcom lays off
- Cibil Score vs Cibil Report
- Birla and Bajaj in top Richest
- Nestle Sept 2023 report
- India Equity Market